JM 50mins, page-37

First 37 Last

Share
Profile

Follow
Robbo3333

2,761 Posts.

292

07/05/22

19:03

Post #: 61268259
Share

Originally posted by tinhat: ↑

That was an excellent interview. Very informative and quite exciting. The one problem with ADN and perhaps also how James sells the story is that it is a movable feast. I guess that is part of the nature of being an industrial materials business. One the one hand the DFS provides a plan to ramping up production of several different types of product over four capital investment stages, but in reality the operation of the business is likely to be a little more complex and nuanced in that we may end up catering with contracts to supply specific clients with customised specs. I think the way JM explains the potential can end up confusing investors.

You might be too young to remember audio cassettes. Back in the day when we would all pirate each other's music cassettes or record the weekly top20 from the radio to play in the car, BASF cassettes were one of the premium quality brands.

@Robbo3333 @stemmo and others. I'm no expert on ASX listing rules and I don't know if this interview was released during trading hours because Crux Investor subscribers get earlier access and the video becomes broadly available after some delay. That said, I can be sure that the announcement will not be marked price sensitive by the ASX because it will most likely be non-binding, subject to conditions and further agreement. Some of the details in the LOI might be subject to non-disclosure or considered commercially sensitive. My experience has been that the ASX is recently more inclined to enforce its anti-pumping stance. It comes down to how the announcement is worded, but they would not consider announcement of a LOI as likely to be information of a material nature that is likely to effect the share price.

Expand

Ha ha. Unfortunately I do remember tape cassettes. Born 1970 probably older than you .My first tape I ever bought was KISS Unmasked ( Detroit Rock city) . I just didn’t realise the connection. Thanks for pointing that out. Cheers

Last edited by Robbo3333: 07/05/22

ADN Price at posting: 9.7¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 100 more messages in this thread...

First 37 Last

Add ADN (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $27.14M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$31.30K	3.922M

Buyers (Bids)

No.	Vol.	Price($)
74	32886173	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	12221494	21

View Market Depth

No.	Vol.	Price($)
74	32886173	0.007
55	20141323	0.006
25	15870122	0.005
7	8025000	0.004
6	18933334	0.003

Price($)	Vol.	No.
0.008	12221494	21
0.009	14753752	12
0.010	6582677	8
0.011	14396522	8
0.012	13445921	6

Last trade - 16.10pm 02/10/2024 (20 minute delay)

ADN (ASX) Chart

JM 50mins, page-37

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

JM 50mins, page-37

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News